TRACT Therapeutics, Inc.

Personalized regulatory T‑cell therapy platform to restore immune balance in solid organ transplant recipients and patients with autoimmune diseases (e.g., Crohn’s). Aims to prevent organ rejection and induce autoimmune remission while reducing or eliminating lifelong toxic immunosuppressive drugs.
Load...
Load...
Load...
Load...
Load...
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...

Insights

Loading Insights...
Q1/2040}
Loading Insight content to display...
Loading Insights...
Q1/2040}
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...

Funding

Workforce

Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
Loading